Atherosclerosis Pathophysiology

Endothelial dysfunction makes the arterial lining more permissive to low-density lipoprotein particles entering the intima, the inner arterial layer. Once retained there, these particles can undergo modification that promotes monocyte recruitment. This early sequence connects vascular lining injury with inflammation and helps explain why lipid exposure and blood pressure are important clinical considerations.

Modified low-density lipoproteins stimulate the recruitment of monocytes into the arterial wall. These cells contribute to the inflammatory response and can develop into foam cells after accumulating lipid. Foam-cell formation is therefore not an isolated lipid-storage event; it reflects the interaction between retained, modified particles and immune activity during plaque development.

Plaque growth can narrow the arterial lumen, but rupture creates an additional danger by exposing plaque material and triggering thrombosis. The resulting clot may further obstruct blood flow and produce an acute ischemic event. This distinction makes plaque stability clinically important: the consequences depend not only on plaque size, but also on whether the plaque remains intact.

The disease process provides a mechanism linking arterial plaque to reduced or interrupted blood flow. Progressive narrowing can limit perfusion, while plaque rupture followed by thrombosis can abruptly worsen obstruction. In clinical interpretation, these mechanisms help connect atherosclerotic changes with ischemic heart disease and stroke rather than viewing those outcomes as unrelated vascular events.

The overview identifies several targets for preventive or therapeutic strategies: lipid levels, inflammation, blood pressure, and plaque stability. These targets correspond to different stages or consequences of the disease process. Evaluating them helps clinicians address both the conditions that support plaque development and the features that increase the likelihood of a dangerous vascular event.

Risk factors can be interpreted by asking how they influence endothelial function, lipid accumulation, inflammation, blood pressure, or plaque stability. This mechanistic approach organizes clinical information around processes that promote arterial disease and its complications. It also supports more focused evaluation of preventive strategies intended to reduce plaque progression or the consequences of rupture.